Bioeconomy Capital
Overview
Bioeconomy Capital is an early-stage venture capital firm that invests in companies operating in the healthcare and biotechnology sectors, with a focus on accelerating the biotechnology revolution.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Synthace | Sep 2017 | Series A | Co-investor |
| Arzeda | Mar 2022 | Series B | Co-investor |
| RoosterBio | Sep 2019 | Series B | Co-investor |
| Lumen Bioscience | Sep 2020 | Series B | Lead |
| Lumen Bio | Sep 2020 | Grant | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bioeconomy Capital based?
Bioeconomy Capital is headquartered in Seattle, Washington, United States.
When was Bioeconomy Capital founded?
Bioeconomy Capital was founded in 2015.
How many portfolio companies does Bioeconomy Capital have?
Bioeconomy Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Bioeconomy Capital's portfolio?
Portfolio companies visible on Caplight include Synthace, Arzeda, RoosterBio, Lumen Bioscience, Lumen Bio.
What was Bioeconomy Capital's most recent investment shown here?
Bioeconomy Capital's most recent investment in this portfolio sample was in Arzeda in 2022.
What sectors does Bioeconomy Capital focus on?
Bioeconomy Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Bioeconomy Capital focus on?
Bioeconomy Capital typically invests at the MultiStage stage.